Literature DB >> 29017616

Quantitative interferon-gamma responses predict future disease progression in badgers naturally infected with Mycobacterium bovis.

S N Buzdugan1, M A Chambers2, R J Delahay3, J A Drewe1.   

Abstract

The diagnosis and control of Mycobacterium bovis infection (bovine tuberculosis: TB) continues to present huge challenges to the British cattle industry. A clearer understanding of the magnitude and duration of immune response to M. bovis infection in the European badger (Meles meles) - a wildlife maintenance host - may assist with the future development of diagnostic tests, and vaccination and disease management strategies. Here, we analyse 5280 diagnostic test results from 550 live wild badgers from a naturally-infected population to investigate whether one diagnostic test (a gamma interferon release [IFNγ] assay, n = 550 tests) could be used to predict future positive results on two other tests for the same disease (a serological test [n = 2342 tests] and mycobacterial culture [n = 2388 tests]) and hence act as an indicator of likely bacterial excretion or disease progression. Badgers with the highest IFNγ optical density (OD) values were most likely to subsequently test positive on both serological and culture tests, and this effect was detectable for up to 24 months after the IFNγ test. Furthermore, the higher the original IFNγ OD value, the greater the chance that a badger would subsequently test positive using serology. Relationships between IFNγ titres and mycobacterial culture results from different types of clinical sample suggest that the route of infection may affect the magnitude of immune response in badgers. These findings identify further value in the IFNγ test as a useful research tool, as it may help us to target studies at animals and groups that are most likely to succumb to more progressive disease.

Entities:  

Keywords:  Diagnosis; epidemiology; immunology; tuberculosis (TB); wildlife

Mesh:

Year:  2017        PMID: 29017616      PMCID: PMC9148748          DOI: 10.1017/S0950268817001960

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  14 in total

1.  Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

Authors:  H Martin Vordermeier; Mark A Chambers; Paul J Cockle; Adam O Whelan; Jennifer Simmons; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  The distribution of Mycobacterium bovis infection in naturally infected badgers.

Authors:  Leigh A L Corner; D O'Meara; E Costello; S Lesellier; E Gormley
Journal:  Vet J       Date:  2012-04-27       Impact factor: 2.688

3.  A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis.

Authors:  J Gallagher; D M Horwill
Journal:  J Hyg (Lond)       Date:  1977-08

4.  Diagnostic accuracy and optimal use of three tests for tuberculosis in live badgers.

Authors:  Julian A Drewe; Alexandra J Tomlinson; Neil J Walker; Richard J Delahay
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

5.  Experimental infection of badgers (Meles meles) with Mycobacterium bovis.

Authors:  D G Pritchard; F A Stuart; J I Brewer; K H Mahmood
Journal:  Epidemiol Infect       Date:  1987-04       Impact factor: 2.451

6.  Association of quantitative interferon-γ responses with the progression of naturally acquired Mycobacterium bovis infection in wild European badgers (Meles meles).

Authors:  Alexandra J Tomlinson; Mark A Chambers; Robbie A McDonald; Richard J Delahay
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

7.  The prevalence, distribution and severity of detectable pathological lesions in badgers naturally infected with Mycobacterium bovis.

Authors:  H E Jenkins; W I Morrison; D R Cox; C A Donnelly; W T Johnston; F J Bourne; R S Clifton-Hadley; G Gettinby; J P McInerney; G H Watkins; R Woodroffe
Journal:  Epidemiol Infect       Date:  2007-11-30       Impact factor: 2.451

8.  Performance of TB immunodiagnostic tests in Eurasian badgers (Meles meles) of different ages and the influence of duration of infection on serological sensitivity.

Authors:  Mark A Chambers; Sue Waterhouse; Konstantin Lyashchenko; Richard Delahay; Robin Sayers; R Glyn Hewinson
Journal:  BMC Vet Res       Date:  2009-11-17       Impact factor: 2.741

9.  Diagnosis of tuberculosis in groups of badgers: an exploration of the impact of trapping efficiency, infection prevalence and the use of multiple tests.

Authors:  S N Buzdugan; M A Chambers; R J Delahay; J A Drewe
Journal:  Epidemiol Infect       Date:  2016-01-06       Impact factor: 4.434

10.  Long-term temporal trends and estimated transmission rates for Mycobacterium bovis infection in an undisturbed high-density badger (Meles meles) population.

Authors:  R J Delahay; N Walker; G C Smith; G S Smith; D Wilkinson; R S Clifton-Hadley; C L Cheeseman; A J Tomlinson; M A Chambers
Journal:  Epidemiol Infect       Date:  2013-03-28       Impact factor: 4.434

View more
  3 in total

1.  Metabotyping the Welsh population of badgers based on thoracic fluid.

Authors:  James Scott-Baumann; Richard Pizzey; Manfred Beckmann; Bernardo Villarreal-Ramos; Jonathan King; Beverley Hopkins; David Rooke; Glyn Hewinson; Luis A J Mur
Journal:  Metabolomics       Date:  2022-05-07       Impact factor: 4.747

2.  Untargeted metabolomic analysis of thoracic blood from badgers indicate changes linked to infection with bovine tuberculosis (Mycobacterium bovis): a pilot study.

Authors:  James Scott Bauman; Richard Pizzey; Manfred Beckmann; Bernardo Villarreal-Ramos; Jonathan King; Beverley Hopkins; David Rooke; Glyn Hewinson; Luis A J Mur
Journal:  Metabolomics       Date:  2022-07-27       Impact factor: 4.747

Review 3.  Review of Methods Used for Diagnosing Tuberculosis in Captive and Free-Ranging Non-Bovid Species (2012-2020).

Authors:  Rebecca Thomas; Mark Chambers
Journal:  Pathogens       Date:  2021-05-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.